Run (or walk) to support patients and their families with ocular melanoma! My name is Dr. Prithvi Mruthyunjaya and I am Director of Ocular Oncology at the Byers Eye Institute at Stanford University. I have dedicated my career to care for patients with eye cancer—and the foe I battle most commonly is ocular melanoma. We know that ocular melanoma may be a rare cancer but there are still questions we don’t have the answer to: why does it develop in the eye, what makes it spread in nearly half of all patients, and why does it still have NO CURE??? The only way to answer these questions is with research.
Since coming to Stanford University in 2016, I have partnered with experts across the medical center to elevate and advance the care of ocular melanoma patients in the Northern California area. The ocular oncology service at Byers Eye Institute is actively engaged in research that may lead to improved vision and survival for ocular melanoma patients. One project we are currently undertaking is using vitreous proteomics to uncover how to diagnose the most dangerous melanomas by taking small samples of fluid from the eye. Using our advanced analysis platform, we are searching for clues from our patients that may help detect tumors at the earliest stages and markers that we can target for new therapies. The impact of these studies may help saves lives.
A Cure in Sight has been an unwavering voice to support and advocate patients and families affected by ocular melanoma. From raising awareness to raising important funding for research, they have been a leading organization in our field. I have worked with A Cure in Sight over the past 4 years and am continued to be impressed with how well they are representing the ocular melanoma community.
The Lookin’ for a Cure 5K Run/Walk for Ocular Melanoma in Palo Alto is the first such event for the ocular melanoma community here in the Bay Area. We look forward to this being an opportunity for the Stanford, Byers Eye Institute and Palo Alto community to show their support for patients and their families with ocular melanoma. We are grateful to know that proceeds from this event will, in part, support ocular oncology research at the Byers Eye Institute.
I look forward to walking with you on Sunday May 20th!
Prithvi Mruthyunjaya, MD, MHS
Associate Professor of Ophthalmology
Ocular Oncology and Vitreoretinal Surgery
Byers Eye Institute at Stanford